(b)(4).A follow-up report will be submitted once the evaluation is complete.This report is being filed on an international product, list number 7k70 that has a similar product distributed in the us, list number 6c06.Complete information for a.Patient information, 1.Patient identifier is (b)(4).
|
An evaluation was performed by reviewing the complaint text, other customer complaints for similar issues, accuracy testing, and review of labeling.A review of complaints determined that there is normal complaint activity and no trends for lot 54704lf00.No patient sample was available to assist in the investigation.Accuracy testing of a serum based panel sample, which mimics a patient sample, was performed using a retained kit of lot 54704lf00.All specifications were met indicating that lot 54704lf00 is performing acceptably.A review of the manufacturing documentation did not identify any issues associated with the customer observation.A review of the product labeling concluded that the complaint issue is sufficiently addressed.Based on all available information and this investigation, the architect total psa, list number (b)(4), lot number 54704lf00, performed as intended and no product deficiency was identified.
|